Patheon

Thermo Fisher Scientific is excited to host an upcoming training on methods and analytical processes for #cell and #genetherapy bioprocessing in partnership with ISCT, International Society for Cell & Gene Therapy. This 3.5-day, in-person course at our facility in #SanDiego, CA, will teach attendees how to refine their skills in #assaydevelopment and standardization of #bioprocessing methods. Register before August 10, 2024: https://lnkd.in/eKjSKzeJ

It can take 10+ years to develop a safe and effective #cellandgenetherapy for patients, a process often complicated by the challenges associated with progressing innovative R&D processes to standardized and robust manufacturing methods. Thermo Fisher Scientific has responded to this industry challenge by developing our Rapid Development Framework™, which can streamline the complexity of #regenerativemedicine and #immunotherapy workflows for cell and gene therapies. Our upcoming webinar in partnership with #PharmaIgnite will take a deep dive into this framework, exploring how it can expedite #drugdevelopment and manufacturing timelines while staying adaptable to the unique needs of each product. Register here: http://spr.ly/6044g0Qj4

Recently, Thermo Fisher Scientific hosted an in-depth webinar discussing how to navigate the complexities of #viralvector production for cutting-edge cell and #genetherapies. The live event featured industry-leading insights from Samira Shore, Anne Gilbert, and Jesse Bishop, specifically covering the following topics: - The intricacies of #viralvector production and strategies to manage and optimize manufacturing processes - Critical #facilitydesign and process considerations for efficient and compliant viral vector production - Insights into the #regulatoryenvironment, including advice on navigating approvals and ensuring compliance - #Casestudies that illustrate common challenges and innovative solutions at various stages of development Whether you're refining small-scale processes or expanding for clinical use, this webinar offers tailored insights for your unique #therapydevelopment program. You can now watch it now on-demand: http://spr.ly/60479yWUR

Time — the often-missing element in pharma development — is on your side with Thermo Fisher Scientific. Our proprietary AI/ML computational modeling empowers you to make informed decisions based on data-driven insights, minimizing the need for costly and resource-intensive experiments. With Thermo Fisher Scientific’s Proprietary Quadrant 2™ platform, you can solve your #smallmolecule’s solubility challenges and make data-driven decisions to advance your formulation development journey. Quadrant 2™ utilizes AI/ML-powered #computationalmodeling to anticipate formulation and technological challenges, offering time and cost savings by replacing traditional trial-and-error methods with a data-based approach for a more efficient #formulationdevelopment process. Learn more about our proprietary AI/ML-powered computational Quadrant 2™ platform: http://spr.ly/6049g0tT9 #Quadrant2 #digitalmodeling #AIcomputationalmodeling

A #biorepository collects, stores, and manages biological samples like tissues, blood, DNA, RNA, and cells for research and clinical purposes. #Biopharma companies often consider outsourcing their #biorepository needs. Outsourcing to a partner like a #CDMO offers access to advanced facilities and expertise at a lower cost. However, it also means losing direct control over operations and may result in delayed access to samples. Ultimately, the decision is yours. Our blog breaks down these pros and cons and provides best practices for ensuring your materials are safe. Read more: http://spr.ly/6046gaiKs

The ability to move from clinical to commercial scale production is a critical aspect of cell and gene therapy. Hear from Kelly Howard, VP of Commercial Operations, VVS Global & Advanced Therapies at Thermo Fisher Scientific, as she discusses the importance of seamless scalability. Learn how utilizing consistent equipment and processes across different scales can facilitate a smoother transition, enhance reliability, and help get critical therapies to patients more quickly. Watch the full discussion below. To learn more about Thermo Fisher Scientific’s comprehensive #CDMO services and solutions for #cellandgenetherapies, visit http://spr.ly/60489OBXy. #Scalability #CellTherapy #GeneTherapy #Biotech #ClinicalToCommercial

“When weighing the benefits and drawbacks of building vs. buying a #biorepository, it’s essential to understand what’s most important: maintaining control over every aspect of #samplestorage or saving time, money, and human resources.” Our blog, “Building a #biorepository: Weighing the benefits and drawbacks,” discusses this topic in detail and explores the pros and cons of building a #biorepository for the collection, preservation, and storage of valuable #biological materials. Additionally, it examines how a #CDMO like Thermo Fisher Scientific can help #biotechnology and #pharmaceutical companies meet their cold and ultra-cold #supplychain needs. Read the blog here: http://spr.ly/6045gagJ3

Are you a #celltherapy developer in the #Philadelphia area? Join Thermo Fisher Scientific for “Sips and cells,” an evening of drinks and hors d’oeuvres, and a chance to explore the latest innovations in #celltherapy development and manufacturing. - Date: Tuesday, July 16, 2024 - Time: 4:00 - 7:00 p.m. EDT - Location: Attico Rooftop Lounge Come network with your industry peers and learn about our comprehensive #CDMO capabilities, spanning #translationalservices to #coldchainlogistics, tailored for #celltherapies like yours. To RSVP, please click here: http://spr.ly/6045gabBW

Part 2 of Thermo Fisher Scientific’s two-part blog series explores how strategic collaborations between #drugsponsors and #CDMOs can help facilitate seamless #techtransfers. It details how a well-chosen partner can help preserve project timelines, overcome common technology transfer challenges, and lead to significant cost savings in #pharmamanufacturing. Additionally, it outlines considerations to look for when choosing a #CDMO partner. Read part 2, “The value of strategic partnerships in pharmaceutical technology transfer,” here: http://spr.ly/6042gabhu

Are you a #drugsponsor developing innovative products like #cellandgenetherapies, #mRNA vaccines, and other #biologics? The logistics of storing, packaging, labeling, and distributing your products might seem secondary, but they are crucial for temperature-sensitive #pharmaceuticals. Cold and ultra-cold chain logistics can make or break the safety and efficacy of these products as they make their way to patients in need, potentially upending years of research, development, and manufacturing efforts. Join Thermo Fisher Scientific's upcoming webinar to dive deep into the challenges and opportunities of #coldchainlogistics and discover industry-leading solutions to ensure the integrity of your #advancedtherapies. Register here: http://spr.ly/6040gak2C